✦ LIBER ✦

PMH7 TREATMENT DURATION WITH ORAL AND LONG ACTING INJECTABLE FORMULATIONS OF TYPICAL ANTIPSYCHOTICS IN THE TREATMENT OF SCHIZOPHRENIA RESULTS ACROSS WORLD GEOGRAPHIES

✍ Scribed by B Zhu; W Montgomery; H Ascher-Svanum; D Faries; DA Stephenson; J McKendrick; A Brnabic; SR Marder

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH67 ORAL SUPPLEMENTATION AND CONCOMITA

✍ H Ascher-Svanum; X Peng; W Montgomery; DE Faries; AH Lawson; M Witte; D Novick; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

PMH12 24-MONTH TREATMENT DISCONTINUATION

✍ JM Olivares; JK Diels; A Rodriguez-Morales; Z Zhao; A Lam 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

P.3.c.058 Interim-analysis of a long-ter

✍ B. Ibach; A. Schreiner 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 61 KB

PMH6 The Impact of Long-Acting Injectabl

✍ M.H. Lafeuille; J. Dean; V. Carter; M.S. Duh; J. Fastenau; R. Dirani; P. Lefebvr 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PMH12 TREATMENT OUTCOMES OF RISPERIDONE

✍ I Tuma; J Pecenak; M Povey; A Lam; Z Zhao 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

PMH12 Risk of Relapse and Hospitalizatio

✍ D. Novick; H. Ascher-Svanum; J. Bertsch; H. Detke; D. Mcdonnell; M. Witte; J. Ha 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB